Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

New England Journal of Medicine

Volumn 325, Issue 3, 1991, Pages 164-170

  Crawford, Jeffrey ^a   Ozer, Howard ^b   Stoller, Ronald ^c   Johnson, David ^d   Lyman, Gary ^e   Tabbara, Imad ^f   Kris, Mark ^g   Grous, John ^h   Picozzi, Vincent ⁱ   Rausch, Gregory ^j   Smith, Roy ^k   Gradishar, William ^l   Yahanda, Anne ^m   Vincent, Martha ⁿ   Stewart, Morgan ⁿ   Glaspy, John ^o  

^a DURHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h Department of Emergency Medicine St Elizabeth's Hospital   (United States)

ⁱ VIRGINIA MASON MEDICAL CENTER   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

^l UNIVERSITY OF CHICAGO   (United States)

^m STANFORD UNIVERSITY   (United States)

ⁿ AMGEN INC   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER THERAPY; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; FEMALE; FEVER; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; SIDE EFFECT; SMALL CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0025800331     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199107183250305     Document Type: Article

References (23)

1. McCabe W.R., Jackson G.G. Gram-negative bacteremia. Arch Intern Med 1962; 110:847-855
2. Bryant R.E., Hood A.F., Hood C.E., Koenig M.G. Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 1971; 127:120-128
3. Pizzo P.A., Hathom J.W., Hiemenz J., et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315:552-558
4. Pizzo P.A., Robichaud K.J., Wesley R., Commers J.R. Fever in the pediatric and young adult patient with cancer: a prospective study of 1001 episodes. Medicine (Baltimore) 1982; 61:153-165
5. Klastersky J. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. In: Senn H-J, Glaus A, Schmid L, eds. Supportive care in cancer patients. Vol. 108 of Recent results in cancer research. Berlin, Germany: Springer-Verlag, 1988: 53-60.
6. Bodey G.P., Buckley M., Sathe Y.S., Freireich E.J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-340
7. Metcalf D. The colony-stimulating factors: discovery, development, and clinical applications. Cancer 1990; 65:2185-2195
8. Groopman J.E., Molina J.-M., Scadden D.T. Hematopoietic growth factors: biology and clinical applications. N Engl J Med 1989; 321:1449-1459
9. Antman K.S., Griffin J.D., Elias A., et al. Effect of recombinant human granulocytemacrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 1988; 319:593-598
10. Souza L.M., Boone T.C., Gabrilove J., et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232:61-65
11. Cohen A.M., Zsebo K.M., Inoue H., et al. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A 1987; 84:2484-2488
12. Platzer E., Weite K., Gabrilove J., et al. Biological activities of human pluripotent hematopoietic colony-stimulating factor on normal and leukemic cells. J Exp Med 1985; 162:1788-1801
13. Gabrilove J.L., Jakubowski A., Fain K., et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988; 82:1454-1461
14. Bronchud M.H., Scarffe J.H., Thatcher N., et al. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56:809-813
15. Morstyn G., Campbell L., Souza L.M., et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1:667-672
16. Gabrilove J.L., Jakubowski A., Scher H., et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med 1988; 318:1414-1422
17. SAS Institute Inc. SAS procedures guide, release 6.03 edition. Cary, N.C.: SAS Institute, 1988.
18. Dixon W.J., ed. BMDP statistical software manual: to accompany the 1988 software release. Berkeley: University of California Press, 1988.
19. Brandt S.J., Peters W.P., Atwater S.K., et al. Effect of recombinant human granulocytemacrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow trans plantation. N Engl J Med 1988; 318:869-876
20. Ohno R., Tomonaga M., Kobayashi T., et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 1990; 323:871-877
21. Talcott J.A., Finberg R., Mayer R.J., Goldman L. The medical course of cancer patients with fever and neutropenia: clinical identification of a low-risk subgroup at presentation. Arch Intern Med 1988; 148:2561-2568
22. de Jongh C.A., Wade J.C., Finley R.S., et al. Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung. J Clin Oncol 1983; 1:302-307
23. Figueredo A.T., Hryniuk W.M., Strautmanis I., Frank G., Rendell S. Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer. J Clin Oncol 1985; 3:54-64.